| NVAX Snapshot | |
|---|---|
| Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland. | |
| VALUATION DATA | |
| Market Capitalization | $586,403,000 | Price to Sales | 1.00 |
| Earnings per Share | $-5.4100 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $3.9500 |
| 52 Week High | $0.609 |
| 52 Week Low | $49.52 |
| 50-Day Moving Average | $0.468 |
| 200-Day Moving Average | $-0.534 |
| All data are from Alpha Vantage as of today. For more infomation on NVAX see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search